臨床微生物学市場：製品タイプ、検体タイプ、エンドユーザー、用途別-2024-2030年の世界予測

臨床微生物学市場規模は2023年に78億米ドルと推計され、2024年には86億8,000万米ドルに達し、CAGR 10.91％で2030年には161億2,000万米ドルに達すると予測されています。

臨床微生物学は広範な検査法を包含し、生物とその分離・同定に使用される方法の点で複雑です。臨床微生物学は感染症の原因となる微生物を調査し、細菌、ウイルス、寄生虫、真菌などの感染性生物を分離・同定して患者を管理・治療することに重点を置いています。感染症の増加、疾病予防の意識の高まり、医療費の増加などが、臨床微生物学の使用を後押ししています。臨床微生物学ラボの品質保証と管理に関する課題は、設備やインフラの限られた利用可能性と相まって、市場への製品浸透の障害となる可能性があります。また、臨床微生物学の機器やプロセスにおける技術的進歩は、医療検査ビジネスがポートフォリオを拡大し、収益性を高めるための様々な機会を提供します。

製品臨床微生物学評価における実験器具の使用

インキュベーター、バイオセーフティキャビネット、遠心分離機、顕微鏡などの検査機器は、臨床微生物学評価において幅広い用途に使用されています。臨床微生物学者は、細菌、古細菌、ウイルス、真菌、原虫などの微小生物を培養、検出、可視化、同定するための特殊な試薬＆分析装置を好みます。臨床試薬・分析装置は、迅速な臨床診断のために微生物の形態、構造、分類、遺伝的変異、生理学、生化学を研究するのに役立ちます。

検体の種類過去または現在の感染症を検出する血清学的検査では、血清検体が好まれます。

血液検体は、敗血症、心内膜炎、その他の全身感染症の原因となる血液由来病原体を検出するために不可欠です。胸水、腹水、心嚢液などの体液は、漿液性腔の感染症の診断に不可欠です。髄液検体は髄膜炎や脳炎などの中枢神経系感染症の診断に不可欠です。糞便検体は消化管感染症の診断や腸内病原菌の抗菌薬耐性のモニタリングに不可欠です。唾液検体は、COVID-19を含む呼吸器感染症の診断において、従来の方法に代わる非侵襲的な方法として近年注目されています。血清検体は、病原体特異的抗体を測定することにより、過去または現在の感染症を検出する血清学的検査に不可欠です。

エンドユーザー：検査室や研究機関における臨床微生物学の採用により、感染症の状態に関する詳細な知見が得られます。

臨床微生物学評価は、臨床検査室、病院・医療機関、学術・研究機関において、病状を効果的に診断するために感染性生物を分離し、その特徴を明らかにするために実施されます。研究所や研究機関では、臨床微生物学の技術を用いて、感染症に関する詳細な洞察をヘルスケア専門家に提供しています。

アプリケーション原因病原体の特定による消化器（GI）疾患の診断に臨床微生物学の利用が増加

関節リウマチやループスを含む自己免疫疾患は、免疫系が健康な細胞を攻撃する病気です。臨床微生物学は、特定の自己抗体や炎症マーカーを特定することで、これらの疾患の診断に役立ちます。臨床微生物学の心臓病学アプリケーションには、心内膜炎や心筋炎などの心臓血管系に影響を及ぼす感染症の診断が含まれます。病原体の迅速な同定は、標的治療と転帰の改善を可能にします。臨床微生物学は、黄色ブドウ球菌などの細菌に感染した尿路感染症や足潰瘍など、血糖コントロールに影響を与えたり合併症を引き起こす可能性のある感染症を特定することで、糖尿病管理の一翼を担っています。薬剤検査では、臨床微生物学は抗菌薬耐性パターンを監視し、感染症治療における適切な治療選択を保証します。臨床微生物学は、Helicobacter pylori（ヘリコバクター・ピロリ）やClostridioides difficile（クロストリジオイデス・ディフィシル）などの原因病原体を特定することで、消化器（GI）疾患の診断に貢献します。腎臓学に特化した微生物検査は、特定の抗菌薬療法を必要とする腎盂腎炎などの腎臓関連の感染症を診断します。臨床微生物学に含まれる腫瘍学アプリケーションでは、治療計画を危うくしたり、合併症の一因となったりするがん関連の感染症を診断します。歯周病では、臨床微生物学は歯科医師が歯肉炎や歯周炎などの症状を引き起こす口腔内の病原菌を特定するのに役立ち、適切な治療法の選択を可能にします。

地域別インサイト

北米では、有力な市場プレイヤーの存在感、研究開発への投資の増加、感染症の蔓延が臨床微生物学の採用を大きく促進しています。米国では製薬・ヘルスケア分野が高度に発展しており、高度な臨床診断技術の採用に拍車をかけています。標的ポリメラーゼ連鎖反応（PCR）のような新しく革新的な微生物学的技術を開拓し、費用対効果を高め、臨床転帰を改善することが、この地域の臨床微生物学市場の成長を強化しています。アジア太平洋地域では、診断の感度を高め、時間対効果を高めるための広域診断や分子診断の人気が高まっており、臨床微生物学の発展に大きく寄与しています。活況を呈する医療ツーリズム産業は、インド、中国、タイ、マレーシアなどのアジア諸国における微生物診断およびモニタリング検査のニーズを高めると予想されます。欧州地域では、病原性疾患の増加、適応菌の発見の増加、迅速な微生物検査法に対するニーズの高まりが、臨床微生物学技術の利用を促進しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは臨床微生物学市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、臨床微生物学市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.臨床微生物学市場の市場規模および予測は？

2.臨床微生物学市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.臨床微生物学市場の技術動向と規制枠組みは？

4.臨床微生物学市場における主要ベンダーの市場シェアは？

5.臨床微生物学市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症の管理と制御における臨床微生物学の使用の増加
    • がんの診断と調査に対する政府と民間団体の好意的な支援と取り組み
  • 抑制要因
    • 熟練した専門家、設備、インフラの不足
  • 機会
    • 臨床微生物学製品およびプロセスにおける技術的進歩
    • ポイントオブケア微生物検査のイントロダクション
  • 課題
    • 臨床微生物学研究室における品質保証と管理に関する問題
• 市場セグメンテーション分析
  • 製品：臨床微生物学評価における実験器具の使用
  • 検体の種類：過去または現在の感染を検出するための血清学的検査では血清サンプルが優先されます
  • エンドユーザー：感染症の病状に関する詳細な情報を提供するために、研究室や調査で臨床微生物学を採用する
  • 応用：原因となる病原体を特定することで、胃腸疾患を診断するための臨床微生物学の使用が増加
• 市場動向分析
  • 高度な臨床微生物学テストを継続的に開発している定評のある市場ベンダーの存在
  • アジア太平洋地域における感染症の蔓延と臨床微生物学製品の改善
  • EMEA地域における感染症の負担を克服するための政府の支援的取り組みと継続的な調査
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 臨床微生物学市場：製品別

• 機器
• 試薬

第7章 臨床微生物学市場標本の種類別

• 血
• 体液
• 脳脊髄液
• 糞便
• 唾液
• 血清
• 滑液
• 尿

第8章 臨床微生物学市場：エンドユーザー別

• 学術調査機関
• 病院と介護サービス提供者
• 研究所

第9章 臨床微生物学市場：用途別

• 自己免疫疾患
• 心臓病学
• 糖尿病
• 薬物検査
• 消化器疾患
• 腎臓学
• 腫瘍学
• 歯周病
• 呼吸器疾患
• 性感染症

第10章 南北アメリカの臨床微生物学市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の臨床微生物学市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの臨床微生物学市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • ウィチタ州立大学のMDL研究所が微生物学へ移行。
  • ケンブリッジのスタートアップ企業が新たな診断法の開発資金を獲得。
  • 微生物学会とインド科学研究所バンガロール校の間で変革協定が締結
  • Hardy Diagnostics社、Premier社と手動微生物学契約を締結
  • 医療微生物学科が総額680万米ドルの4つの新プロジェクトと新しいウェブサイトを公開。
  • ASMが包括的微生物学リーダープログラムに資金提供。
  • MAESTRIAは、Biomerieuxが開発した、研究室のワークフローを最適化し、患者ケアを改善する新世代の微生物学ミドルウェアです。
  • Beckman Coulter社とMeMed社は、ウイルス感染と細菌感染を区別できる実証済みの宿主免疫応答診断へのアクセスを拡大します。
  • BDが微生物学研究室向けに完全自動化ロボットトラックシステムを導入。
  • FASTinovはBeckman Coulter Life Sciencesと提携し、臨床微生物学ラボに超高速2h-ASTの革新的なテクノロジーを導入します。
  • アップステートは、ライム病およびダニ媒介性疾患の多分野にわたる治療センターの開設を計画しています。
  • Bio-RadがAbbott診断プラットフォームのQC範囲を拡大。
  • 連邦政府の資金により、アルバータ大学の感染力の高い病原体への対応能力が強化される予定。
  • オックスフォード大学、ヘルスケア調査のために1億2,200万ポンド（1億3,663万米ドル）の資金を獲得。
  • Sci-Tech DaresburyのPerfectus Biomed Groupが、医療機器試験の世界的リーダーであるNAMSAに買収されました。
  • HORIBA Veterinary、診断が難しい寄生虫を検査する新たな迅速PCR検査を追加。
  • ValitaCellがBeckman Coulter Life Sciencesに加わりました。
  • Global Access DiagnosticsがBio-Rad LaboratoriesからIT-LEISH迅速診断テストの製造権を取得。
  • SSI Diagnosticaは力強い成長を続けています。
  • BDとAccelerate Diagnosticsが世界の商業提携を発表。
  • SGSはアリゾナ州フェニックスに新しい微生物学研究所を開設しました。
  • イスラエル：イスラエルの微生物診断企業PocaredにEUが2,200万ユーロ（2,426万米ドル）を援助。
  • DCN Dxが微生物学的検査製品会社Biomed Diagnosticsを買収。
  • bioMerieuxは、迅速なASTソリューションに重点を置く革新的企業であるSpecific Diagnosticsを買収し、抗菌薬耐性と戦う取り組みを強化しました。
  • NIHが新しい結核調査推進センターに資金提供。
  • RaueがSonicヘルスケアによるDiagnosticum Laboratory Groupの買収について助言。
  • ATCCは、QIAGENとの提携によりバイオインフォマティクスデータプラットフォームを拡張することを発表しました。
  • Hardy DiagnosticsがBioCode MDx-3000の提供を開始しました。
  • メルクは、CDMOの提供を強化し、将来の成長を加速するために、ライフサイエンス事業部門の組織改革を発表しました。
  • COPAN Diagnosticsは、臨床微生物学における人工知能の進化における新たな大きな一歩を発表しました。

第14章 競争力のあるポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CLINICAL MICROBIOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. CLINICAL MICROBIOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CLINICAL MICROBIOLOGY MARKET DYNAMICS
• FIGURE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CLINICAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 62. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 63. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 64. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 65. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 66. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 67. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 68. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 69. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 70. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 71. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 72. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 73. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 74. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 75. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 76. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 77. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 80. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 81. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 82. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 83. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 84. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 85. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 88. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 89. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 90. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 91. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 92. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 93. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 96. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 97. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 98. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 99. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 100. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 101. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 102. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 103. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 104. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 105. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 106. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 107. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 108. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 109. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 110. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 111. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 112. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 114. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 116. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 118. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 120. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 122. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 123. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 124. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 125. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 126. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 127. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 128. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 129. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 132. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 133. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 134. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 135. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 136. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 137. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 138. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 139. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 140. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 141. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 142. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 143. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 144. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 145. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 146. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 147. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 148. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 149. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 150. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 151. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 152. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 153. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 154. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 155. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 156. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 157. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 158. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 159. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 160. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 161. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 164. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 165. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 166. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 167. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 168. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 169. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 170. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 171. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 172. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 173. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 174. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 175. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 176. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 177. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 178. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 179. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 180. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 181. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 182. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 183. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 184. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 185. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 186. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 187. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 188. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 189. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 190. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 191. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 192. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 193. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 194. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 195. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 196. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 197. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 198. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 199. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 200. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 201. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 202. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 203. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 204. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 205. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 206. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 207. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 208. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 209. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 210. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 211. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 212. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 213. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 214. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 215. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 216. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 217. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 218. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 228. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 229. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 230. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 231. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 232. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 233. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 234. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 235. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 236. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 237. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 238. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 239. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 240. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 241. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 242. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 243. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 244. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 245. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 246. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 247. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 248. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 249. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 250. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 251. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 252. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 253. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 254. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 255. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 256. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 257. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 258. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 259. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 260. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 261. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 262. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 263. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 264. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 265. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 266. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 267. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 268. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 269. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 270. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 271. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 272. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 273. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 274. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 275. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 276. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 277. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 278. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 279. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 280. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 281. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 282. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 283. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 284. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 285. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 286. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 287. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 288. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 289. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 290. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 291. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 292. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 293. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 294. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 295. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 296. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 297. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 298. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 299. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 300. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 301. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 302. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 303. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 304. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 305. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 306. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 307. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 308. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 309. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 310. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 311. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 312. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 313. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 314. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 315. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 316. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 317. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 318. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 319. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 320. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 321. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 322. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 323. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 324. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 325. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 326. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 327. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 328. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 329. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 330. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 331. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 332. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 333. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 334. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 335. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 336. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 337. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 338. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 339. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 340. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 341. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 342. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 343. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
• TABLE 344. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
• TABLE 345. SOUTH AFRICA CLINICAL MICROBIOLOGY

[189 Pages Report] The Clinical Microbiology Market size was estimated at USD 7.80 billion in 2023 and expected to reach USD 8.68 billion in 2024, at a CAGR 10.91% to reach USD 16.12 billion by 2030.

Clinical microbiology encompasses a wide range of testing methods, and it is complex in terms of organisms and methods used to isolate & identify them. Clinical microbiology investigates microorganisms that cause infectious diseases and focuses on isolating and characterizing infectious organisms such as bacteria, viruses, parasites, and fungi to manage and treat patients. The increasing occurence of infectious diseases, growing awareness of disease prevention, and increasing healthcare expenditure are all factors driving the use of clinical microbiology. Problems concerning quality assurance and management in clinical microbiology laboratories coupled with limited availability of equipment and infrastructure can pose a challenge to product penetration in the market. Additionally, technological advancement in clinical microbiology instruments and processes presents various opportunities for medical laboratory businesses to expand their portfolio and increase profitability.

Product: Use of laboratory instruments in clinical microbiology assessments

Laboratory instruments such as incubators, biosafety cabinets, centrifuges, and microscopes include a wide scope of applications in clinical microbiology assessments. Clinical microbiologists prefer specialized reagents & analyzers to culture, detect, visualize, and identify microscopic organisms such as bacteria, archaea, viruses, fungi, or protozoa. Clinical reagents & analyzers aid in studying the morphology, structure, classification, genetic variation, physiology, and biochemistry of microorganisms for rapid clinical diagnostics.

Specimen Type: Preference for serum samples in serological testing to detect past or current infections

Blood specimens are essential for detecting bloodborne pathogens responsible for sepsis, endocarditis, and other systemic infections. Body fluids such as pleural, peritoneal, or pericardial fluid are crucial for diagnosing infections in serous cavities. CSF specimens are critical in diagnosing central nervous system infections, including meningitis or encephalitis. Fecal specimens are crucial for diagnosing gastrointestinal infections and monitoring antimicrobial resistance in enteric pathogens. Saliva specimens have gained attention in recent years as non-invasive alternatives to traditional methods for diagnosing respiratory infections, including COVID-19. Serum samples are essential for serological testing to detect past or current infections by measuring pathogen-specific antibodies.

End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions

Clinical microbiology assessments are performed at clinical laboratories, hospitals & care providers, and academic & research institutes to isolate and characterize infectious organisms for diagnosing disease conditions effectively. Laboratories and research institutes provide detailed insights regarding infectious disease conditions to healthcare professionals using clinical microbiology techniques.

Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens

Autoimmune diseases, including rheumatoid arthritis and lupus, involve the immune system attacking healthy cells. Clinical microbiology helps diagnose these conditions by identifying specific autoantibodies or inflammatory markers. Cardiology applications in clinical microbiology include diagnosing infections that affect the cardiovascular system, such as endocarditis and myocarditis. Rapid identification of pathogens enables targeted treatment and improved outcomes. Clinical microbiology plays a role in diabetes management by identifying infections that may impact blood glucose control or cause complications, such as urinary tract infections or foot ulcers infected by bacteria such as Staphylococcus aureus. In drug testing, clinical microbiology monitors antimicrobial resistance patterns to ensure appropriate therapeutic choices for infectious disease treatment. Clinical microbiology contributes to diagnosing gastrointestinal (GI) diseases by identifying causative pathogens, such as Helicobacter pylori or Clostridioides difficile. Nephrology-focused microbiology tests diagnose kidney-related infections, such as pyelonephritis, which requires specific antimicrobial therapies. Oncology applications within clinical microbiology involve diagnosing cancer-related infections that can compromise treatment plans or contribute to complications. In periodontal diseases, clinical microbiology helps dentists identify oral pathogens responsible for conditions such as gingivitis and periodontitis, enabling appropriate treatment selection.

Regional Insights

In North America, the strong presence of leading market players, increasing investments in research & development, and the growing prevalence of infectious diseases significantly increase the adoption of clinical microbiology. Highly developed pharmaceutical and healthcare sectors in the United States are fueling the adoption of advanced clinical diagnostic techniques. Developing new and innovative microbiological technologies, such as targeted polymerase chain reactions (PCRs), to increase cost-effectiveness and improve clinical outcomes is strengthening the market growth of clinical microbiology across the region. In Asia-Pacific, the growing popularity of broad-range and molecular diagnosis to surge the sensitivity of diagnosis while promoting time effectiveness significantly contributes to the development of clinical microbiology. The booming medical tourism industry is expected to increase the need for microbial diagnostic and monitoring tests in Asian countries such as India, China, Thailand, and Malaysia. In the Europe region, the increasing prevalence of pathogenic diseases, growth in the discovery of adapting bacterium, and the rising need for speedy microbiological testing methods enhance the utilization of clinical microbiology technology.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Microbiology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Microbiology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Microbiology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Instruments, LLC, Agilent Technologies, Inc., B. Braun SE, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux S.A., Cardinal Health, Inc., Clinichem Ltd., COPAN Diagnostics Inc., Diagnostica Longwood S.L., ELITech Group, F. Hoffmann-La Roche Ltd., Hardy Diagnostics, HORIBA, Ltd., Kyokuto Pharmaceutical Industrial Co., Ltd., Laboratorios Conda, S.A., Liofilchem S.r.l., Merck KGaA, Prestige Diagnostics U.K. Ltd., Pro Lab Diagnostics Inc., QIAGEN N.V., Rapid Micro Biosystems, Inc., Shimadzu Corporation, SSI Diagnostica A/S, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., and Vircell S.L..

Market Segmentation & Coverage

This research report categorizes the Clinical Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Instruments
  • Reagents

• Specimen Type
  • Blood
  • Body fluids
  • Cerebrospinal Spinal Fluid
  • Fecal
  • Saliva
  • Serum
  • Synovial Fluid
  • Urine

• End-User
  • Academic & Research Institutes
  • Hospitals & Care Providers
  • Laboratories

• Application
  • Autoimmune Diseases
  • Cardiology
  • Diabetes
  • Drug Testing
  • Gastrointestinal Diseases
  • Nephrology
  • Oncology
  • Periodontal Diseases
  • Respiratory Diseases
  • Sexually Transmitted Diseases

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Microbiology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Microbiology Market?

3. What are the technology trends and regulatory frameworks in the Clinical Microbiology Market?

4. What is the market share of the leading vendors in the Clinical Microbiology Market?

5. Which modes and strategic moves are suitable for entering the Clinical Microbiology Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use of clinical microbiology in managing and controlling infectious diseases
    • 5.1.1.2. Favorable government and private organizations support, and initiatives in cancer diagnosis and research
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of skilled professionals, equipment and infrastructure
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement in clinical microbiology products and processes
    • 5.1.3.2. Introduction of point-of-care microbiology testing
  • 5.1.4. Challenges
    • 5.1.4.1. Problems concerning quality assurance and management in clinical microbiology laboratories
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Use of laboratory instruments in clinical microbiology assessments
  • 5.2.2. Specimen Type: Preference for serum samples in serological testing to detect past or current infections
  • 5.2.3. End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions
  • 5.2.4. Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens
• 5.3. Market Trend Analysis
  • 5.3.1. Presence of well-established market vendors with the ongoing development of advanced clinical microbiology testings
  • 5.3.2. Prevalence of infectious disease and improvements in clinical microbiology products in APAC
  • 5.3.3. Supportive government initiatives and ongoing research to overcome the burden of infectious diseases in the EMEA region
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis

6. Clinical Microbiology Market, by Product

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents

7. Clinical Microbiology Market, by Specimen Type

• 7.1. Introduction
• 7.2. Blood
• 7.3. Body fluids
• 7.4. Cerebrospinal Spinal Fluid
• 7.5. Fecal
• 7.6. Saliva
• 7.7. Serum
• 7.8. Synovial Fluid
• 7.9. Urine

8. Clinical Microbiology Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Hospitals & Care Providers
• 8.4. Laboratories

9. Clinical Microbiology Market, by Application

• 9.1. Introduction
• 9.2. Autoimmune Diseases
• 9.3. Cardiology
• 9.4. Diabetes
• 9.5. Drug Testing
• 9.6. Gastrointestinal Diseases
• 9.7. Nephrology
• 9.8. Oncology
• 9.9. Periodontal Diseases
• 9.10. Respiratory Diseases
• 9.11. Sexually Transmitted Diseases

10. Americas Clinical Microbiology Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Clinical Microbiology Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Microbiology Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Wichita State's MDL Lab Shifting To Microbiology.
  • 13.3.2. Cambridge Start-Up Won Funding To Develop New Diagnostics.
  • 13.3.3. Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore
  • 13.3.4. Hardy Diagnostics Awarded Manual Microbiology Agreement With Premier, Inc.
  • 13.3.5. Department of Medical Microbiology Unveils Four New Projects Worth USD 6.8 Million and New Website.
  • 13.3.6. ASM Funded for Inclusive Microbiology Leaders Program.
  • 13.3.7. MAESTRIA, A New Generation Microbiology Middleware Developed by Biomerieux to Optimize Laboratory Workflow and Improve Patient Care.
  • 13.3.8. Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Viral and Bacterial Infections.
  • 13.3.9. BD Introduces Fully Automated Robotic Track System for Microbiology Labs.
  • 13.3.10. FASTinov Collaborates with Beckman Coulter Life Sciences to Bring Ultra-Rapid 2h-AST Disruptive Technology to Clinical Microbiology Laboratories.
  • 13.3.11. Upstate Planned To Launch A Multidisciplinary Lyme And Tick-Borne Disease Treatment Center.
  • 13.3.12. Bio-Rad Expands QC Range for Abbott Diagnostic Platforms.
  • 13.3.13. Federal Funds Set To Boost U of A's Ability To Handle Highly Infectious Pathogens.
  • 13.3.14. Oxford Gets £122m (USD 136.63 Million) Funding for Healthcare Research.
  • 13.3.15. Sci-Tech Daresbury's Perfectus Biomed Group Acquired by Global Medical Device Testing Leader NAMSA.
  • 13.3.16. HORIBA Veterinary Adds New Rapid PCR Test for Difficult to Diagnose Parasite.
  • 13.3.17. ValitaCell Joins Beckman Coulter Life Sciences.
  • 13.3.18. Global Access Diagnostics Acquires Manufacturing Rights for IT-LEISH Rapid Diagnostic Test From Bio-Rad Laboratories.
  • 13.3.19. SSI Diagnostica Continues a Strong Growth Journey.
  • 13.3.20. BD, Accelerate Diagnostics Announce Global Commercial Collaboration.
  • 13.3.21. SGS Launched New Microbiology Laboratory In Phoenix, Arizona.
  • 13.3.22. Israel: EUR 22 Million (Usd 24.26 Million) EU Backing for Israeli Microbiology Diagnostic Player Pocared.
  • 13.3.23. DCN Dx Acquires Microbiological Testing Products Company Biomed Diagnostics.
  • 13.3.24. bioMerieux Strengthens its Commitment to Fight Antimicrobial Resistance with the Acquisition of Specific Diagnostics, An Innovative Company Focusing on Fast AST Solutions.
  • 13.3.25. NIH Funded New Tuberculosis Research Advancement Centers.
  • 13.3.26. Raue Advises Sonic Healthcare on the Acquisition of Diagnosticum Laboratory Group.
  • 13.3.27. ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN.
  • 13.3.28. Hardy Diagnostics Now Offers the BioCode MDx-3000.
  • 13.3.29. Merck Announced Organizational Transformation of Life Science Business Sector To Strengthen Cdmo Offering And Accelerate Future Growth.
  • 13.3.30. COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology.

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio